期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY LetPub Score 5.2
50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 7.0 | ||||||||||||||||||||||||||||
期刊簡稱 | IMMUNOPHARM IMMUNOT | ||||||||||||||||||||||||||||
ISSN | 0892-3973 | ||||||||||||||||||||||||||||
E-ISSN | 1532-2513 | ||||||||||||||||||||||||||||
h-index | 42 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://www.tandfonline.com/toc/iipi20/current | ||||||||||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/lipi | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Informa Healthcare | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||||||||||
每年文章數 | 59每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 4.26% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0892-3973%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY] 的評論 | 撰寫評論 |
作者: 碧波庆彬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-23 18:35:17 評論於 Does this journal accept submissions by invitation only?(0) 讚! | 碧波庆彬 |
作者: 123&$ 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-21 21:12:24 評論於 Submitted in mid-January, revised by the end of May (minor revisions), the manuscript was returned by the end of May. It was sent for external review for another month and a half. Revised again at the beginning of July (minor revisions for adding two lines), now unsure if it needs to be sent for external review for another month and a half. Please be cautious when submitting urgently.(0) 讚! | 123&$ |
作者: 一条小冬荷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-11 17:58:41 評論於 No need.(0) 讚! | 一条小冬荷 |
作者: 一条小冬荷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-11 16:50:47 評論於 No need.(0) 讚! | 一条小冬荷 |
作者: 上清明喆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-08 18:55:43 評論於 Research focus: Immunological memory sharing. Does this require a page fee?(0) 讚! | 上清明喆 |
作者: 四风家欣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-02 18:29:47 評論於 After receiving on 06.22, I have not received the proof yet as of 07.04. May I ask how long it took for you to receive it?(0) 讚! | 四风家欣 |
作者: 四风家欣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-02 13:34:03 評論於 I looked at the wrong time, it is 07.03.(0) 讚! | 四风家欣 |
作者: 无妄华晖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-30 11:18:46 評論於 Hello, may I ask how long it takes for your article to go through the submission, review process, and acceptance? Thank you for your answer!(0) 讚! | 无妄华晖 |
作者: 香风正平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-05 10:02:22 評論於 Hello, how long did it take for your article to be accepted after submission?(0) 讚! | 香风正平 |
作者: 孤云良才 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-21 13:03:18 評論於 Not yet(0) 讚! | 孤云良才 |
作者: 碧水夏旋 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-02 22:08:04 評論於 Hello, have you replied to your article?(0) 讚! | 碧水夏旋 |
作者: 孤云良才 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-27 21:32:57 評論於 Who knows the reminder email address of this journal? It has been over a month and they still haven't sent me the proof. It's driving me crazy(0) 讚! | 孤云良才 |
作者: 孤云良才 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-22 09:46:38 評論於 After this journal accepted the article, I have been waiting for over a month and still haven't received the proof. I have sent reminders twice but have not received any replies. What's going on?(0) 讚! | 孤云良才 |
作者: 贼努力 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2023-02-12 18:48:15 評論於 The first SCI paper of my life was published in this journal, which is friendly to research novices. Now I have become a reviewer for this journal. In mid-2018, I passed one paper, and now I am sharing the timeline for reference. 2018-8-30: Submitted 2018-9-30: Minor revision 2018-11-10: Re-submitted 2018-12-3: Accepted(0) 讚! | 贼努力 |
作者: 邻家梓淇 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-12 09:04:22 評論於 Review speed: 1.0 | Submission hit rate: 95.0 Research focus: Environmental pollutants; Cytokines Experience sharing: My first sci paper was published in this journal, which is friendly to research novices. I am now a reviewer for this journal. I passed one paper in 2018 and am sharing the timeline for reference. 2018-8-30 submit 2018-9-30 minor revision 2018-11-10 re-submit 2018-12-3 accept(0) 讚! | 邻家梓淇 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:54:28 評論於 Differences in presentation form(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:41:51 評論於 Bar charts use the height of the bars to reflect differences in data, and the human eye is very sensitive to differences in height. Line graphs are generally used to represent trends, with the horizontal axis usually representing dates; they easily reflect trends in data changes(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 15:47:09 評論於 When to use bar charts and when to use line charts?(0) 讚! | 陶宜三岁啦 |
作者: 修然小公主 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 18:55:25 評論於 Bar charts use the height of bars to reflect differences in data, and the human eye is very sensitive to differences in height. Line charts are generally used to show trends, with the horizontal axis typically being a date field; they easily reflect trends in data changes(0) 讚! | 修然小公主 |
作者: Randolph Pigou 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-14 11:29:01 評論於 Please translate the following passage into English and Japanese, and title them respectively as ":" and ":"(0) 讚! | Randolph Pigou |
作者: 紫霞怡然 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-20 19:14:35 評論於 Can we be co-corresponding authors?(0) 讚! | 紫霞怡然 |
作者: Randolph Pigou 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-23 23:03:44 評論於 Review Speed: 2.0 Experience Sharing: submitted, edited within a week, first review nearly 2 months, major revision, second review 3 weeks, minor revision, third review 3 weeks, accepted(0) 讚! | Randolph Pigou |
作者: 水月夜柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-21 19:21:16 評論於 Already published, two months, very efficient!(0) 讚! | 水月夜柔 |
作者: 水月夜柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-07-16 23:06:39 評論於 Has anyone submitted anything recently? I wonder how long it takes for this magazine to review submissions. It's been almost two months since I submitted mine, and it's still under review(0) 讚! | 水月夜柔 |
作者: 北斗智志 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-10-31 09:59:19 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Experience sharing: Weekend also processing manuscripts, editorial department dedicated(0) 讚! | 北斗智志 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us